Literature DB >> 31364924

Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Dominic P Del Re1, Dulguun Amgalan1, Andreas Linkermann1, Qinghang Liu1, Richard N Kitsis1.   

Abstract

Twelve regulated cell death programs have been described. We review in detail the basic biology of nine including death receptor-mediated apoptosis, death receptor-mediated necrosis (necroptosis), mitochondrial-mediated apoptosis, mitochondrial-mediated necrosis, autophagy-dependent cell death, ferroptosis, pyroptosis, parthanatos, and immunogenic cell death. This is followed by a dissection of the roles of these cell death programs in the major cardiac syndromes: myocardial infarction and heart failure. The most important conclusion relevant to heart disease is that regulated forms of cardiomyocyte death play important roles in both myocardial infarction with reperfusion (ischemia/reperfusion) and heart failure. While a role for apoptosis in ischemia/reperfusion cannot be excluded, regulated forms of necrosis, through both death receptor and mitochondrial pathways, are critical. Ferroptosis and parthanatos are also likely important in ischemia/reperfusion, although it is unclear if these entities are functioning as independent death programs or as amplification mechanisms for necrotic cell death. Pyroptosis may also contribute to ischemia/reperfusion injury, but potentially through effects in non-cardiomyocytes. Cardiomyocyte loss through apoptosis and necrosis is also an important component in the pathogenesis of heart failure and is mediated by both death receptor and mitochondrial signaling. Roles for immunogenic cell death in cardiac disease remain to be defined but merit study in this era of immune checkpoint cancer therapy. Biology-based approaches to inhibit cell death in the various cardiac syndromes are also discussed.

Entities:  

Keywords:  apoptosis; cell death; heart disease; necroptosis; necrosis

Mesh:

Substances:

Year:  2019        PMID: 31364924      PMCID: PMC6890986          DOI: 10.1152/physrev.00022.2018

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  567 in total

Review 1.  Mechanisms of cell death in heart disease.

Authors:  Klitos Konstantinidis; Russell S Whelan; Richard N Kitsis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

2.  MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.

Authors:  Cole M Dovey; Jonathan Diep; Bradley P Clarke; Andrew T Hale; Dan E McNamara; Hongyan Guo; Nathaniel W Brown; Jennifer Yinuo Cao; Christy R Grace; Peter J Gough; John Bertin; Scott J Dixon; Dorothea Fiedler; Edward S Mocarski; William J Kaiser; Tudor Moldoveanu; John D York; Jan E Carette
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

3.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

Authors:  H Nishimura; T Okazaki; Y Tanaka; K Nakatani; M Hara; A Matsumori; S Sasayama; A Mizoguchi; H Hiai; N Minato; T Honjo
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

4.  Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury.

Authors:  Sang-Bing Ong; Sapna Subrayan; Shiang Y Lim; Derek M Yellon; Sean M Davidson; Derek J Hausenloy
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

5.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt.

Authors:  L del Peso; M González-García; C Page; R Herrera; G Nuñez
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

6.  Programmed cell death in the myocardium of arrhythmogenic right ventricular cardiomyopathy in children and adults.

Authors:  T Nishikawa; S Ishiyama; M Nagata; Y Sakomura; M Nakazawa; K Momma; M Hiroe; T Kasajima
Journal:  Cardiovasc Pathol       Date:  1999 Jul-Aug       Impact factor: 2.185

Review 7.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

8.  Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts.

Authors:  Hui-Zhong Zhou; Raymond A Swanson; Ursula Simonis; Xiaokui Ma; Gary Cecchini; Mary O Gray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-03-31       Impact factor: 4.733

9.  Autophagic cell death is dependent on lysosomal membrane permeability through Bax and Bak.

Authors:  Jason Karch; Tobias G Schips; Bryan D Maliken; Matthew J Brody; Michelle A Sargent; Onur Kanisicak; Jeffery D Molkentin
Journal:  Elife       Date:  2017-11-17       Impact factor: 8.140

10.  Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models.

Authors:  N Takahashi; L Duprez; S Grootjans; A Cauwels; W Nerinckx; J B DuHadaway; V Goossens; R Roelandt; F Van Hauwermeiren; C Libert; W Declercq; N Callewaert; G C Prendergast; A Degterev; J Yuan; P Vandenabeele
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

View more
  145 in total

1.  Chemical activation of SAT1 corrects diet-induced metabolic syndrome.

Authors:  Federico Pietrocola; Guido Kroemer; Francesca Castoldi; Mervi T Hyvönen; Sylvère Durand; Fanny Aprahamian; Allan Sauvat; Shoaib A Malik; Elisa Elena Baracco; Erika Vacchelli; Paule Opolon; Nicolas Signolle; Déborah Lefevre; Noelie Bossut; Tobias Eisenberg; Christopher Dammbrueck; Tobias Pendl; Margerie Kremer; Sylvie Lachkar; Claudia Einer; Bernhard Michalke; Hans Zischka; Frank Madeo; Tuomo A Keinänen; Maria Chiara Maiuri
Journal:  Cell Death Differ       Date:  2020-05-06       Impact factor: 15.828

2.  COP9 Signalosome Suppresses RIPK1-RIPK3-Mediated Cardiomyocyte Necroptosis in Mice.

Authors:  Peng Xiao; Changhua Wang; Jie Li; Huabo Su; Liuqing Yang; Penglong Wu; Megan T Lewno; Jinbao Liu; Xuejun Wang
Journal:  Circ Heart Fail       Date:  2020-06-24       Impact factor: 8.790

3.  RhoA signaling increases mitophagy and protects cardiomyocytes against ischemia by stabilizing PINK1 protein and recruiting Parkin to mitochondria.

Authors:  Michelle Tu; Valerie P Tan; Justin D Yu; Raghav Tripathi; Zahna Bigham; Melissa Barlow; Jeffrey M Smith; Joan Heller Brown; Shigeki Miyamoto
Journal:  Cell Death Differ       Date:  2022-06-27       Impact factor: 15.828

Review 4.  Sterile inflammation in thoracic transplantation.

Authors:  C Corbin Frye; Amit I Bery; Daniel Kreisel; Hrishikesh S Kulkarni
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

5.  Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes.

Authors:  Wendy M McKimpson; Yun Chen; James A Irving; Min Zheng; Jeremy Weinberger; Wilson Lek Wen Tan; Zenia Tiang; Alistair M Jagger; Streamson C Chua; Jeffrey E Pessin; Roger S-Y Foo; David A Lomas; Richard N Kitsis
Journal:  Dev Cell       Date:  2021-03-04       Impact factor: 12.270

Review 6.  Role of iron homeostasis in the heart : Heart failure, cardiomyopathy, and ischemia-reperfusion injury.

Authors:  Hangying Ying; Zhida Shen; Jiacheng Wang; Binquan Zhou
Journal:  Herz       Date:  2021-05-12       Impact factor: 1.443

Review 7.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

8.  Liproxstatin-1 protects the mouse myocardium against ischemia/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels.

Authors:  Yansheng Feng; Ngonidzashe B Madungwe; Abdulhafiz D Imam Aliagan; Nathalie Tombo; Jean C Bopassa
Journal:  Biochem Biophys Res Commun       Date:  2019-10-14       Impact factor: 3.575

Review 9.  Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.

Authors:  Xin-Ming Liu; Sheng-Li Du; Ran Miao; Le-Feng Wang; Jiu-Chang Zhong
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

10.  FoxO4 negatively modulates USP10 transcription to aggravate the apoptosis and oxidative stress of hypoxia/reoxygenation-induced cardiomyocytes by regulating the Hippo/YAP pathway.

Authors:  Jingwen Huang; Yu Liu; Mei Wang; Rong Wang; Huifen Ling; Yan Yang
Journal:  J Bioenerg Biomembr       Date:  2021-07-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.